214450.KQ
PharmaResearch Co., Ltd.
KOE · Healthcare · Biotechnology · KR
KRW 381,000.00
−2.93%Year over year
Reported trailing growth
- Revenue
- +34.1%
- EBITDA
- -17.6%
- EBIT
- +39.1%
- EPS
- +45.6%
- Free cash flow
- +21.9%
- Operating cash flow
- +17.3%
Forward estimates
Based on analyst estimates
- Revenue
- +25.8%
- EBITDA
- +28.3%
- EPS
- -7.6%
Three-year CAGR
- Revenue
- +40.1%
- EBITDA
- +43.9%
- EBIT
- +47.7%
- Net income
- +59.7%
- EPS
- +57.5%
- Free cash flow
- +54.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026